Skip to content

US · LNAI

Lunai Bioworks Inc.

Programmatic access: InvestorsCraft Valuation API · catalog

Sector
Healthcare · Biotechnology
Headquarters
Los Angeles, CA 90067

Price · as of 2026-09-04

$2.39

Market cap 11.24M

Price history

Weekly OHLC price history for LNAI, USD per share
WeekOpenHighLowCloseVolume
Sep 1, 2025 – Sep 5, 2025$19.60$19.60$16.00$16.560
Sep 8, 2025 – Sep 12, 2025$16.64$17.84$14.56$15.920
Sep 15, 2025 – Sep 19, 2025$16.40$17.52$12.80$14.000
Sep 22, 2025 – Sep 26, 2025$14.24$14.40$10.32$10.400
Sep 29, 2025 – Oct 3, 2025$10.24$12.40$9.04$10.320
Oct 6, 2025 – Oct 10, 2025$10.32$11.12$8.96$9.040
Oct 13, 2025 – Oct 17, 2025$9.20$11.20$8.88$9.600
Oct 20, 2025 – Oct 24, 2025$10.00$10.24$7.22$8.640
Oct 27, 2025 – Oct 31, 2025$8.48$8.80$6.80$6.960
Nov 3, 2025 – Nov 7, 2025$6.88$12.24$6.48$7.460
Nov 10, 2025 – Nov 14, 2025$7.12$9.52$6.48$8.480
Nov 17, 2025 – Nov 21, 2025$8.80$13.28$7.84$9.920
Nov 24, 2025 – Nov 28, 2025$9.92$12.16$7.68$9.440
Dec 1, 2025 – Dec 5, 2025$9.36$10.64$8.88$10.000
Dec 8, 2025 – Dec 12, 2025$9.92$11.20$8.48$8.560
Dec 15, 2025 – Dec 19, 2025$8.56$8.80$7.70$8.400
Dec 22, 2025 – Dec 26, 2025$8.48$8.88$7.56$7.770
Dec 29, 2025 – Jan 2, 2026$8.08$8.08$6.88$7.770
Jan 5, 2026 – Jan 9, 2026$7.76$8.32$7.04$7.680
Jan 12, 2026 – Jan 16, 2026$7.36$7.98$7.12$7.400
Jan 19, 2026 – Jan 23, 2026$7.20$7.44$6.56$7.020
Jan 26, 2026 – Jan 30, 2026$6.89$7.74$6.00$6.240
Feb 2, 2026 – Feb 6, 2026$6.42$6.69$5.04$5.300
Feb 9, 2026 – Feb 13, 2026$5.60$8.96$5.36$5.880
Feb 16, 2026 – Feb 20, 2026$5.44$5.57$4.19$4.360
Feb 23, 2026 – Feb 27, 2026$4.44$4.64$2.90$2.960
Mar 2, 2026 – Mar 6, 2026$3.00$3.29$1.85$1.860
Mar 9, 2026 – Mar 13, 2026$1.88$1.90$1.21$1.480
Mar 16, 2026 – Mar 20, 2026$1.45$5.91$1.37$3.750
Mar 23, 2026 – Mar 27, 2026$3.45$7.58$2.80$3.300
Mar 30, 2026 – Apr 2, 2026$3.13$3.32$2.98$2.980
Apr 6, 2026 – Apr 10, 2026$2.97$4.34$2.24$2.970
Apr 13, 2026 – Apr 17, 2026$2.89$3.04$2.10$2.790
Apr 20, 2026 – Apr 24, 2026$2.69$2.80$2.29$2.480
Apr 27, 2026 – May 1, 2026$2.32$2.78$2.26$2.560
May 4, 2026 – May 8, 2026$3.01$3.27$2.06$2.640
May 11, 2026 – May 15, 2026$2.68$2.68$2.01$2.060
May 18, 2026 – May 22, 2026$2.07$2.40$1.75$2.260
May 25, 2026 – May 29, 2026$2.17$3.24$2.02$3.080
Jun 1, 2026 – Jun 5, 2026$2.94$3.38$2.45$2.450
Jun 8, 2026 – Jun 12, 2026$2.46$2.79$2.25$2.410
Jun 15, 2026 – Jun 18, 2026$2.43$5.02$2.43$3.780
Jun 22, 2026 – Jun 26, 2026$3.09$4.78$3.09$3.210
Jun 29, 2026 – Jul 2, 2026$3.17$3.47$3.01$3.200
Jul 6, 2026 – Jul 10, 2026$3.20$3.25$2.65$2.940
Jul 13, 2026 – Jul 17, 2026$2.94$3.01$2.71$2.820
Jul 20, 2026 – Jul 24, 2026$2.78$3.09$2.31$2.330
Jul 27, 2026 – Jul 31, 2026$2.33$2.37$1.94$1.940
Aug 3, 2026 – Aug 7, 2026$2.00$3.78$1.91$2.410
Aug 10, 2026 – Aug 14, 2026$2.45$2.47$2.15$2.220
Aug 17, 2026 – Aug 21, 2026$2.25$2.30$2.12$2.150
Aug 24, 2026 – Aug 28, 2026$2.16$2.50$2.10$2.370
Aug 31, 2026 – Sep 4, 2026$2.38$2.49$2.15$2.390

Valuation

MetricValueUpside
IC Value
P/E-0.19
P/B-1.60
P/S
EV/EBITDA-0.25
PEG-1.04
P/TBV-1.24

Valuation history

Annual price overlaid with each model's fair value. Y-axis is log scale.

Annual price and model valuations for LNAI, USD per share
YearPriceAIICGraham-DoddGraham Formula
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021$630.40
2022$164.80
2023$256.00
2024$49.68
2025$16.56

Historic valuation ratios

Pick a category, then toggle metrics to compare.

USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Lunai Bioworks Inc.

        Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."

        CEO
        David H. Weinstein
        Employees
        29
        Beta
        0.35

        Peer comparison

        Same-industry comparables, ranked by market cap.

        Scroll horizontally for additional metrics. Ticker column stays fixed.

        Peer comparison for LNAI: basic info, valuation models, ratios, profitability, leverage, growth, cash flow, dividends, enterprise value, and Altman Z-score.
        Basic InfoIC ValuationCore ValuationProfitabilityLeverage & LiquidityGrowthCash FlowDividendsEnterprise ValueRisk
        TickerCompany NamePriceMarket CapValueUpsideP/EP/BP/SEV/EBITDAPEGP/TBVGross MarginOperating MarginNet MarginROEROICROADebt/EquityInterest CoverageCurrent RatioQuick RatioNet Debt/EBITDAEPS GrowthSales GrowthFCF GrowthFCF YieldOp Cash Flow RatioCash ROICDividend YieldDividend PayoutShareholder YieldEV/EBITEV/FCFEV/SalesAltman Z-Score
        LNAILunai Bioworks Inc.$2.4111.24M-0.19-1.60-0.25-1.04-1.240.00%0.00%0.00%-321.81%-29.94%-207.76%-0.48-25.560.040.02-0.0618.46%-28.68%-23.05%-0.27-12.71%0.00%0.00%0.00%-2.36-5.57-97.67
        ANLAdlai Nortye Ltd.$13.28704.9M-2.38-10.1816.95-2.68-10.16100.00%-713.96%-710.56%-415.10%512.53%-67.40%-3.17-23.990.650.60-0.08-31.90%-35.13%-39.80%-0.81484.23%0.00%0.00%0.00%-2.45-2.5917.46-21.50
        APLMApollomics, Inc.$16.9018.65M$457.37+2,606%-2.63-9.023.38-2.83-9.0297.00%-111.45%-128.69%-1305.01%194.18%-110.40%-0.20-145.740.960.910.29-85.66%4192.93%-63.96%-36.06%-1.64212.54%0.00%0.00%0.00%-2.76-2.523.07-150.11
        BLRXBioLineRx Ltd.$2.7111.79M$134.36+4,858%-9.260.609.22-1.096.0036.19%-871.78%-99.58%-7.48%-126.38%-2.97%0.56-8.041.951.76-30.70-93.72%-95.89%-81.42%-74.41%-0.67-99.50%0.00%0.00%0.00%-0.02-0.030.21-13.82
        ERNAErnexa Therapeutics Inc.$4.211.32M$1.74-59%-0.140.84-0.05-0.345.650.00%0.00%0.00%-686.69%-1117.18%-253.70%0.20-345.151.010.640.1042.68%-100.00%-56.47%-349.51%-2.25-848.35%0.00%0.00%17.29%-0.07-0.09-63.86
        GOVXGeoVax Labs, Inc.$0.775.67M$26.11+3,291%-0.080.430.660.030.44-628.02%-869.34%-862.34%-483.79%-3849.83%-296.11%0.222.741.590.10-81.41%-37.06%-12.94%-1304.29%-11.09-3825.38%0.00%0.00%0.00%0.030.03-0.24-43.13
        ICUSeaStar Medical Holding C…$3.289.31M$59.84+1,724%-4.375.1043.01-3.425.1095.71%-986.63%-984.60%-295.15%545.11%-129.15%0.05-37.013.633.260.94-91.16%814.07%-15.04%-25.62%-3.63608.87%0.00%0.00%19.24%-3.42-3.0633.72-8.41
        LPCNLipocine Inc.$2.1312.36M$12,561.78+589,655%-4.152.7620.23-2.670.002.76-334.26%-524.69%-487.06%-54.28%3245.49%-48.73%0.036.685.910.50105525.00%-82.35%644.34%-24.41%-3.863054.40%0.00%0.00%0.00%-2.46-2.6112.91-8.63
        MBRXMoleculin Biotech, Inc.$0.412.19M-0.070.160.180.630.00%0.00%0.00%-319.85%-579.34%-171.88%0.021.411.300.25-84.97%-4.77%-940.82%-3.32-524.69%0.00%0.00%195.28%0.240.27-16.42

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $2.39) − 1 = — (IC, example).